I have selected my own “top ten” for 2016. The papers I chose go beyond our “most-read” and “most-shared” articles, which, this year, were disproportionately on topics related to health care costs.

For the past two years, Health Affairs has published blog posts arising from the Center for Healthcare Management’s forums, held in Berlin. These events are unlike a typical conference—more conversation than presentation, and more participation by various actors in the health care sector than...

Last week I was interviewed for Politico’s Pulse Check podcast about my role as Editor-in-Chief of Health Affairs and how the journal shapes health policy.

Last week I was interviewed by Dmitri Sotus on WTOP’s "To Your Health” about the state of competition in the ACA marketplaces. Listen to the podcast episode and get a preview of our June issue.

In an interview on WTOP, I discuss the recent Supreme Court decision in Gobeille v. Liberty Mutual Insurance Co. and its impact on state efforts to control health care costs.

As Health Affairs Editor-in-Chief, I have the pleasure of reading hundreds of articles. I have selected my own “top ten” for 2015. The papers I chose go beyond our “most-read” articles, which tend to be on topics tied to the highest profile policy issues of the day.

With average yearly treatment costs exceeding $100,000, cancer drugs in the US cost nearly twice as much as anywhere else in the world. It can be difficult to find any correlation between a drug’s price and the social value or efficacy of the drug.

When we heard about threats to the Agency for Healthcare Research and Quality’s (AHRQ) future, we set out to understand how the loss of AHRQ would affect the nation’s understanding of critical health policy issues. The results caused us great concern.

I knew I would learn a great deal when I attended Spotlight Health at the Aspen Ideas Festival. Still, this session included experts whose views I had not yet heard (including the future CEO of Project HOPE).

Yesterday I appeared on C-SPAN’s Washington Journal where I answered questions about the role of subsidies in the federal insurance marketplaces.